Related Experiment Videos

[Glucocorticosteroids in the treatment of subglottic laryngitis in children]

Beata Zielnik-Jurkiewicz1

  • 1Oddział Otolaryngologiczny, SZPZOZ im. Prof. J. Bogdanowicza w Warszawie.

Insights

Subglottic laryngitis, a severe childhood illness, involves sudden breathing difficulties. Nebulized budesonide offers a safe and effective treatment option for children with moderate to severe cases.

Area of Science:

  • Pediatric Pulmonology
  • Emergency Medicine
  • Pharmacology

Context:

  • Subglottic laryngitis is an acute pediatric respiratory emergency characterized by rapid onset of subglottic edema.
  • Symptoms include barking cough, stridor, inspiratory dyspnea, and potential for severe respiratory distress.
  • This condition can be life-threatening in young children.

Purpose:

  • To evaluate the efficacy of nebulized glucocorticoids, specifically budesonide, in treating subglottic laryngitis in children.
  • To assess the safety and effectiveness of budesonide nebulization for moderate to severe cases.

Summary:

  • A study involving 169 children (9 months to 5 years) with subglottic laryngitis assessed treatment outcomes.
  • Patients received nebulized budesonide, and disease severity was evaluated using a clinical croup score.
  • Results demonstrated that nebulized budesonide is a safe and effective treatment for moderate to severe subglottic laryngitis.

Impact:

  • Nebulized budesonide provides a safe and effective therapeutic option for pediatric subglottic laryngitis.
  • This treatment can potentially reduce the severity and duration of respiratory distress in affected children.
  • Findings support the use of budesonide as a key intervention in managing this acute pediatric condition.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...